Buprenorphine Market, By Brand (Sublocade (buprenorphine extended‐release), Suboxone (buprenorphine and naloxone), Brixadi (buprenorphine extended‐release), Zubsolv (buprenorphine and naloxone), and Others (Belbuca, Butrans and among others)), By Type (Branded and Generics), By Route of Administration (Injectable (Intravenous, Intramuscular, Subcutaneous), Sublingual, Buccal, Transdermal, and Others), By Dosage Form (Injectable Solutions, Patches, Films, Others (Tablets, etc.)), By Indication (Opioid Use Disorder (OUD), Pain Management, Acute Pain, Chronic Pain), By Formulation Type (Single Drug Formulation, Fixed Dose Combination), By Age Group (Adults, Pediatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)